BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  PT010 Phase III ETHOS trial met its primary endpoint in chronic obstructive pulmonary disease

  AstraZeneca announced positive results from the Phase III ETHOS trial for triple-combination therapy PT010 in patients with moderate to very severe chronic obstructive pulmonary disease.

  August 28, 2019

   · 

  7 min read
• Biotech Bay

  Rigel’s CEO to Participate in Panel Discussion at Citi’s 14th Annual Biotech Conference

  The panel entitled “The Fascinating World of ‘Benign’ Hematology” will be held on Thursday, September 5, 2019 from 8:00 am – 8:40 am Eastern Time.

  August 28, 2019

   · 

  1 min read
• Business

  BiondVax Welcomes New Chairman of the Board and Announces Second Quarter 2019 Financial Results

  Professor Avner Rotman, who has served as BiondVax’s Chairman since 2005, will continue to serve as a Director.

  August 28, 2019

   · 

  7 min read
• Business

  BioLife Solutions Strengthens Sales Team with Key Leadership Additions

  BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced the hiring of two key sales executives who will assist in building and leading the worldwide sales organization

  August 28, 2019

   · 

  2 min read
• Business

  Medivir AB - Interim Report January - June 2019

  Several advances in the clinical portfolio

  August 28, 2019

   · 

  8 min read
• Business

  Lannett Enters Into Distribution Agreement For Posaconazole Delayed-Release Tablets; Launch To Commence Shortly

  Lannett Company, Inc. announced that it has entered into an agreement with Sinotherapeutics Inc., a China-based specialty pharmaceutical company, to be the exclusive U.S. distributor of Posaconazole Delayed-Release Tablets 100mg.

  August 28, 2019

   · 

  2 min read
• Biotech Bay

  Veeva Expands Veeva Vault Regulatory Capabilities for Medical Device and Diagnostics

  Modern cloud technology enables device and diagnostics manufacturers to keep pace with changing regulations and growing complexity

  August 28, 2019

   · 

  5 min read
• Deals

  Cadent Therapeutics to Present at Upcoming Investor Conferences - Aug. 28, 2019

  Cadent Therapeutics announced that Jodie Morrison, the Company’s Chief Executive Officer, will present at the following upcoming investor conferences

  August 28, 2019

   · 

  1 min read
• Job Trends

  The Advantages of Cloud Robotics Are Gaining Attention with Global Revenue Expected to Reach $170.4 Billion by 2025, According to Tractica

  According to a new report from Tractica, cloud robotics, which is a combination of cloud computing and robotics technologies in the form of hardware, software, and services, is differentiated from general robotics through the use of teleoperation and cloud technologies.

  August 28, 2019

   · 

  2 min read
• Biotech Beach

  BIOLASE to Participate at Dougherty & Company Institutional Investor Conference on September 5, 2019

  President and CEO Todd Norbe and Executive Vice President and CFO John Beaver will hold one-on-one and small group meetings with institutional investors throughout the day.

  August 28, 2019

   · 

  1 min read